Literature DB >> 19377901

Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome.

Takako Saeki1, Tomoyuki Ito, Hajime Yamazaki, Naofumi Imai, Shinichi Nishi.   

Abstract

Recently, a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome (IgG4+ MOLPS), characterized by hyper-IgG4 gammaglobulinemia and IgG4-positive plasma cell tissue infiltration, has been proposed. It includes autoimmune pancreatitis (AIP), Mikulicz's disease, and many other inflammatory conditions affecting multiple organs. However, diagnosis is difficult if the disease is not suspected because serum IgG subclasses are not measured routinely and the affected organs vary. Because hypocomplementemia is often observed in this condition, we investigated the serum subclasses of IgG in patients with hypocomplementemia, especially of unknown etiology. We found 6 patients with high serum IgG4 levels among 10 patients with hypocomplementemia of unknown etiology who visited our hospital between December 2004 and September 2007. The results of additional pathological and imaging examinations in the 6 patients with high serum IgG4 levels were compatible with IgG4+ MOLPS. Our results suggest that hypocomplementemia of unknown etiology offers an opportunity to find cases of IgG4+ MOLPS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377901     DOI: 10.1007/s00296-009-0925-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings.

Authors:  Naoki Takahashi; Akira Kawashima; Joel G Fletcher; Suresh T Chari
Journal:  Radiology       Date:  2007-01-17       Impact factor: 11.105

2.  Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family.

Authors:  Yasuni Nakanuma; Yoh Zen
Journal:  Hepatol Res       Date:  2007-10       Impact factor: 4.288

Review 3.  Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS).

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuyoshi Naishiro; Hiroyuki Isshiki; Mikiko Ohara; Chisako Suzuki; Hiroyuki Yamamoto; Yasuo Kokai; Tetsuo Himi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2008-02

4.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

5.  Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy.

Authors:  Aki Kuroki; Takanori Shibata; Hirokazu Honda; Daisuke Totsuka; Kenji Kobayashi; Tetsuzo Sugisaki
Journal:  Intern Med       Date:  2002-11       Impact factor: 1.271

6.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

7.  Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease.

Authors:  Takako Saeki; Akihiko Saito; Tohru Hiura; Hajime Yamazaki; Iwao Emura; Mitsuhiro Ueno; Syoji Miyamura; Fumitake Gejyo
Journal:  Intern Med       Date:  2006-03-01       Impact factor: 1.271

8.  Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.

Authors:  Suresh T Chari; Thomas C Smyrk; Michael J Levy; Mark D Topazian; Naoki Takahashi; Lizhi Zhang; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Michael B Farnell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-14       Impact factor: 11.382

9.  Tubulointerstitial nephritis associated with IgG4-related systemic disease.

Authors:  Takako Saeki; Akihiko Saito; Hajime Yamazaki; Iwao Emura; Naofumi Imai; Mitsuhiro Ueno; Shinichi Nishi; Syoji Miyamura; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

10.  Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis.

Authors:  T Saeki; N Imai; T Ito; H Yamazaki; S Nishi
Journal:  Clin Nephrol       Date:  2009-02       Impact factor: 0.975

View more
  6 in total

Review 1.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

Review 2.  IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty.

Authors:  Hideaki Hamano; Eiji Tanaka; Nobukazu Ishizaka; Shigeyuki Kawa
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

Review 3.  Immune Dysregulation in IgG4-Related Disease.

Authors:  Jiachen Liu; Wei Yin; Lisa S Westerberg; Pamela Lee; Quan Gong; Yan Chen; Lingli Dong; Chaohong Liu
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

4.  Immune Complex-Mediated Complement Activation in a Patient with IgG4-Related Tubulointerstitial Nephritis.

Authors:  Seiji Nagamachi; Isao Ohsawa; Nobuyuki Sato; Masaya Ishii; Gaku Kusaba; Takashi Kobayashi; Yukihiko Takeda; Satoshi Horikoshi; Hiroyuki Ohi; Misao Matsushita; Yasuhiko Tomino
Journal:  Case Rep Nephrol Urol       Date:  2011-08-18

5.  IgG4-related disease of the rectum.

Authors:  Sung-Bong Choi; Chul-Hyun Lim; Myung-Guen Cha; Won-Kyung Kang
Journal:  Ann Surg Treat Res       Date:  2016-05-02       Impact factor: 1.859

6.  New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases.

Authors:  Kazunori Yamada; Motohisa Yamamoto; Takako Saeki; Ichiro Mizushima; Shoko Matsui; Yuhei Fujisawa; Satoshi Hara; Hiroki Takahashi; Hideki Nomura; Shigeyuki Kawa; Mitsuhiro Kawano
Journal:  Arthritis Res Ther       Date:  2017-12-01       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.